APM
ABBV icon

Avidity Partners Management’s AbbVie ABBV Stock Holding History

Avidity Partners Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,800
Closed -$4.58M – 40
2025
Q3 		$4.58M Buy
+19,800
New +$4.03M 1.04% 23
2025
Q1 		– Sell
-80,700
Closed -$14.3M – 68
2024
Q4 		$14.3M Sell
80,700
-19,300
-19% -$3.55M 1.41% 32
2024
Q3 		$19.7M Sell
100,000
-177,800
-64% -$33.2M 1.01% 39
2024
Q2 		$47.6M Buy
277,800
+50,800
+22% +$8.41M 2.02% 16
2024
Q1 		$41.3M Sell
227,000
-57,405
-20% -$9.89M 1.33% 28
2023
Q4 		$44.1M Buy
+284,405
New +$41.5M 1.61% 27
2023
Q3 		– Sell
-518,400
Closed -$69.8M – 84
2023
Q2 		$69.8M Buy
+518,400
New +$76M 2.44% 9
2022
Q3 		– Sell
-755,000
Closed -$116M – 98
2022
Q2 		$116M Sell
755,000
-711,100
-49% -$109M 2.65% 16
2022
Q1 		$238M Sell
1,466,100
-518,900
-26% -$75.4M 4.95% 3
2021
Q4 		$269M Buy
1,985,000
+371,800
+23% +$43.9M 5.7% 1
2021
Q3 		$174M Buy
1,613,200
+128,800
+9% +$14.7M 3.86% 5
2021
Q2 		$167M Sell
1,484,400
-592,800
-29% -$66.8M 4.52% 2
2021
Q1 		$225M Buy
2,077,200
+721,200
+53% +$77.1M 6.21% 1
2020
Q4 		$145M Sell
1,356,000
-166,800
-11% -$16M 4.72% 3
2020
Q3 		$133M Sell
1,522,800
-22,600
-1% -$2.13M 6.19% 2
2020
Q2 		$152M Buy
1,545,400
+1,068,400
+224% +$94.1M 9.72% 1
2020
Q1 		$36.3M Buy
477,000
+383,000
+407% +$32.6M 5.02% 3
2019
Q4 		$8.32M Buy
+94,000
New +$7.8M 5.24% 4

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Avidity Partners Management's ABBV Position: Q4 2025 in Review

Avidity Partners Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 19,800 shares — an estimated $4.58M sold.

Avidity Partners Management first reported a position in ABBV in Q4 2019 and held it in 18 quarters. The position peaked at $269M in Q4 2021. 4,156 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Avidity Partners Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Avidity Partners Management sold 19,800 AbbVie shares in Q4 2025, an estimated $4.58M.
  • Avidity Partners Management first reported a position in AbbVie in Q4 2019 and held it in 18 quarters.
  • Avidity Partners Management's AbbVie position peaked at $269M in Q4 2021.
  • 4,156 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Avidity Partners Management's 13F filing for Q4 2025, filed 13 Feb 2026.